Skip to content

Study · Non-randomized trial · 2018

2 results

[Cognitive control impairment in adult with attention deficit/hyperactivity disorder].

Chutko LS, Surushkina SY, Yakovenko EA, Anisimova TI, Antokhin EY, Kryukova EY

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2018Cited by 2 (Europe PMC)

PMID30698557 (opens in a new tab)DOI10.17116/jnevro201811812131 (opens in a new tab)PepBankPUB-30698557
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In adults with ADHD, significant cognitive control improvement after Cerebrolysin was reported in 42.1% of patients.

    In plain wordsIn adults with ADHD, significant cognitive control improvement after Cerebrolysin was reported in 42.1% of patients.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseSignificant cognitive control improvement proportion
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Significant improvement
    42.1%
    Patients

    Source sentences

    Summary
    The results of the study showed that cerebrolysin was an effective tool for improving cognitive control in adult patients with ADHD (a significant improvement was noted in 42.1% of patients, improvement in 31.6% of patients).
    1 context sentence
    Summary · context
    Thirty-eight patients with ADHD, aged from 18 to 45 years were enrolled in the study.
  2. 02HumanNon-randomized trialEfficacy outcome

    In adults with ADHD, cognitive control improvement after Cerebrolysin was reported in 31.6% of patients.

    In plain wordsIn adults with ADHD, cognitive control improvement after Cerebrolysin was reported in 31.6% of patients.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseCognitive control improvement proportion
    Study

    n: not reported in source

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Improvement
    31.6%
    Patients

    Source sentences

    Summary
    The results of the study showed that cerebrolysin was an effective tool for improving cognitive control in adult patients with ADHD (a significant improvement was noted in 42.1% of patients, improvement in 31.6% of patients).
    1 context sentence
    Summary · context
    Thirty-eight patients with ADHD, aged from 18 to 45 years were enrolled in the study.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.